首页> Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer> A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Rudolph M,Navari

第一单位： Notre Dame Cancer Institute, University of Notre Dame, 224 Raclin-Carmichael Hall, Notre Dame, IN 46556, USA. Navari.1@nd.edu.;Indiana University School of Medicine South Bend, South Bend, IN, USA. Navari.1@nd.edu.

作者： Rudolph M,Navari ^[1] ; Lawrence H,Einhorn ^[2] ; Patrick J,Loehrer ^[2] ; Steven D,Passik ^[3] ; Jake,Vinson ^[4] ; John,McClean ^[5] ; Naveed,Chowhan ^[6] ; Nasser H,Hanna ^[2] ; Cynthia S,Johnson ^[7]

作者单位： Notre Dame Cancer Institute, University of Notre Dame, 224 Raclin-Carmichael Hall, Notre Dame, IN 46556, USA. Navari.1@nd.edu.;Indiana University School of Medicine South Bend, South Bend, IN, USA. Navari.1@nd.edu. ^[1] Division of Hematology-Oncology, Indiana University Medical Center, Indianapolis, IN, USA.;Indiana University Cancer Center, Indianapolis, IN, USA. ^[2] Memorial Sloan-Kettering Cancer Center, New York, NY, USA. ^[3] Hoosier Oncology Group, Indianapolis, IN, USA. ^[4] Medical and Surgical Specialists, Galesburg, IL, USA. ^[5] Cancer Care Center, New Albany, IN, USA. ^[6] Division of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA. ^[7]